Jingjing He , Mengjie Shen , Xin Ye , Xiuhong Ren , Ke Chen , Jiangxu Zhang , Weijun Fan , Zhongmin Wang , Yin Xu
{"title":"Expert consensus on perioperative management for liver tumors treated with co-ablation system therapy","authors":"Jingjing He , Mengjie Shen , Xin Ye , Xiuhong Ren , Ke Chen , Jiangxu Zhang , Weijun Fan , Zhongmin Wang , Yin Xu","doi":"10.1016/j.apjon.2024.100591","DOIUrl":null,"url":null,"abstract":"<div><div>Co-ablation system therapy is currently in its early stages of application in tumor treatment in China. The associated protocols for perioperative management are not yet well-developed and suffer from a lack of corresponding guidelines or consensus. This study aims to improve the quality of clinical treatment and nursing care and to standardize perioperative management for patients with liver tumors undergoing co-ablation system therapy. The Committee of Ablation Therapy in Oncology, China Anti-Cancer Association, and the Committee of Interventional Perioperative, Interventional Physician Branch of the Chinese Medical Doctor Association organized medical and nursing experts in China. Based on the clinical practice of co-ablation system therapy in China and the relevant domestic literature, an expert consensus regarding perioperative management was developed. The expert consensus includes the key points of perioperative management, prevention and care of complications, discharge guidance, and follow-up management for patients who have undergone co-ablation system therapy of liver tumors. The consensus on the perioperative management of co-ablation system therapy for liver tumors has finally been formulated, providing a reference and application for medical personnel in relevant fields based on hospital and patient conditions in clinical work.</div></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia-Pacific Journal of Oncology Nursing","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2347562524002130","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
Abstract
Co-ablation system therapy is currently in its early stages of application in tumor treatment in China. The associated protocols for perioperative management are not yet well-developed and suffer from a lack of corresponding guidelines or consensus. This study aims to improve the quality of clinical treatment and nursing care and to standardize perioperative management for patients with liver tumors undergoing co-ablation system therapy. The Committee of Ablation Therapy in Oncology, China Anti-Cancer Association, and the Committee of Interventional Perioperative, Interventional Physician Branch of the Chinese Medical Doctor Association organized medical and nursing experts in China. Based on the clinical practice of co-ablation system therapy in China and the relevant domestic literature, an expert consensus regarding perioperative management was developed. The expert consensus includes the key points of perioperative management, prevention and care of complications, discharge guidance, and follow-up management for patients who have undergone co-ablation system therapy of liver tumors. The consensus on the perioperative management of co-ablation system therapy for liver tumors has finally been formulated, providing a reference and application for medical personnel in relevant fields based on hospital and patient conditions in clinical work.